Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $8.45M | 12,810,377 | 51.46% | 48.54% | ||||
| FBLG | FIBROBIOLOGICS INC | $7.71M | 3,379,736 | 40.87% | 59.13% | Net Buying | Net Buying | ||
| CODX | CO-DIAGNOSTICS INC | $3.45M | 2,029,753 | 34.31% | 65.69% | Net Selling | |||
| PSTV | PLUS THERAPEUTICS INC | $36.88M | 171,550,698 | 6.73% | 13.93% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $69.11M | 33,067,630 | 9.51% | 90.49% | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $103.30M | 336,494,489 | 18.50% | 9.46% | Net Selling | Net Selling | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $29.92M | 55,815,653 | 14.12% | 21.18% | ||||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.02M | 839,662 | 27.53% | 72.47% | Net Selling | |||
| IMMP | IMMUTEP LTD | $51.58M | 1,473,721,306 | 0.13% | 0.00% | ||||
| HELP | CYBIN INC | $215.54M | 49,894,131 | 60.30% | 0.00% | ||||
| ENLV | ENLIVEX LTD | $213.64M | 237,381,498 | 0.56% | 9.27% | ||||
| GUTS | FRACTYL HEALTH INC | $67.74M | 158,648,963 | 70.87% | 18.33% | Net Buying | |||
| HUMA | HUMACYTE INC | $127.66M | 222,019,108 | 24.91% | 13.85% | Net Selling | |||
| OSTX | OS THERAPIES INC | $46.84M | 35,214,352 | 5.04% | 18.78% | Net Selling | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $94.38M | 123,692,286 | 36.22% | 33.04% | Net Selling | |||
| SNTI | SENTI BIOSCIENCES INC | $24.04M | 31,144,497 | 17.99% | 82.01% | ||||
| TVRD | TVARDI THERAPEUTICS INC | $30.02M | 9,381,344 | 8.39% | 91.61% | ||||
| VNRX | VOLITIONRX LTD | $23.33M | 122,801,572 | 13.15% | 33.07% | Net Buying | Net Selling | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $1.60M | 1,057,612 | 1.48% | 98.52% | Net Buying | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $17.98M | 24,602,405 | 1.41% | 3.40% | ||||
| HOVR | NEW HORIZON AIRCRAFT LTD | $57.53M | 44,252,749 | 2.82% | 20.61% | Net Selling | |||
| FEMY | FEMASYS INC | $21.99M | 58,479,824 | 16.18% | 4.17% | Net Buying | |||
| ACRV | ACRIVON THERAPEUTICS INC | $49.98M | 38,744,446 | 48.03% | 38.25% | Net Selling | Net Buying | ||
| ACET | ADICET BIO INC | $58.63M | 9,596,407 | 29.18% | 70.82% | Net Buying | Net Selling | ||
| CTSO | CYTOSORBENTS CORP | $35.17M | 62,804,305 | 26.85% | 45.21% | Net Buying | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $32.76M | 27,074,586 | 1.76% | 98.24% | ||||
| NSRX | NASUS PHARMA LTD | $18.12M | 9,015,383 | 0.03% | 57.27% | ||||
| CAN | CANAAN INC | $257.05M | 9,939,193,337 | 1.62% | 3.73% | ||||
| IFRX | INFLARX NV | $60.15M | 72,292,859 | 26.80% | 6.01% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $134.54M | 216,998,876 | 31.61% | 38.17% | Net Selling | Net Selling | ||
| INTZ | INTRUSION INC | $16.93M | 20,369,066 | 7.93% | 74.72% | Net Buying | Net Selling | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $118.84M | 117,667,277 | 22.52% | 11.52% | Net Selling | Net Selling | ||
| CCCC | C4 THERAPEUTICS INC | $229.31M | 97,578,175 | 80.10% | 19.90% | Net Selling | Net Selling | ||
| GNLX | GENELUX CORP | $103.05M | 44,805,811 | 20.34% | 6.29% | Net Selling | Net Selling | ||
| AVXL | ANAVEX LIFE SCIENCES CORP | $261.33M | 92,671,758 | 40.78% | 4.79% | Net Buying | |||
| RCT | REDCLOUD HOLDINGS PLC | $30.03M | 44,226,639 | 0.80% | 20.60% | ||||
| CABA | CABALETTA BIO INC | $274.97M | 111,322,671 | 68.49% | 3.91% | Net Buying | Net Buying | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $338.00M | 266,143,286 | 52.34% | 0.53% | ||||
| APRE | APREA THERAPEUTICS INC | $8.46M | 11,452,452 | 2.77% | 97.23% | Net Buying | Net Buying | ||
| CLNN | CLENE INC | $56.77M | 11,778,307 | 6.84% | 93.16% | Net Selling | Net Selling | ||
| FGNX | FG NEXUS INC | $32.85M | 6,530,207 | 21.25% | 78.75% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $95.44M | 72,299,440 | 32.13% | 25.19% | Net Buying | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $38.73M | 48,596,817 | 25.49% | 74.51% | Net Selling | Net Selling | ||
| ATOS | ATOSSA THERAPEUTICS INC | $40.56M | 8,611,361 | 60.10% | 39.90% | Net Buying | |||
| IVVD | INVIVYD INC | $336.29M | 282,594,729 | 72.23% | 27.77% | Net Selling | Net Selling | ||
| FEAM | 5E ADVANCED MATERIALS INC | $50.64M | 41,511,883 | 19.89% | 80.11% | Net Buying | Net Buying | ||
| LUNG | PULMONX CORP | $49.84M | 42,237,203 | 76.70% | 20.51% | Net Selling | Net Selling | ||
| VERI | VERITONE INC | $156.07M | 91,806,023 | 30.05% | 33.16% | Net Buying | Net Selling | ||
| TCRX | TSCAN THERAPEUTICS INC | $53.49M | 56,901,623 | 53.94% | 29.91% | Net Buying | |||
| PALI | PALISADE BIO INC | $295.27M | 165,884,817 | 81.91% | 5.00% | Net Buying | Net Buying | ||
| ALIT | ALIGHT INC | $297.72M | 534,502,781 | 72.59% | 27.41% | Net Buying | Net Buying | ||
| CRBU | CARIBOU BIOSCIENCES INC | $166.22M | 96,637,202 | 38.43% | 8.91% | Net Selling | Net Selling | ||
| CING | CINGULATE INC | $67.91M | 11,628,613 | 4.41% | 37.95% | Net Buying | Net Buying | ||
| MNOV | MEDICINOVA INC | $66.94M | 49,221,246 | 10.68% | 88.78% | ||||
| CRVO | CERVOMED INC | $33.52M | 9,258,719 | 3.05% | 96.95% | Net Buying | |||
| ALT | ALTIMMUNE INC | $374.60M | 130,069,983 | 42.17% | 48.78% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.